Key Takeaways
- President Donald Trump announced a major breakthrough in psychedelic medicine as the University of Miami gifted its original 1994 Ibogaine Investigational New Drug (IND) application to the federal government.
- The move aims to provide "direct access" to foundational FDA data, accelerating the development of Ibogaine as a treatment for serious mental illness and addiction under the Right to Try Act.
- Tensions in the Middle East reached a critical point as Iran’s Foreign Minister Abbas Araghchi declared that Tehran has "won both the war and diplomacy," rejecting ceasefire talks and shifting to a "fully offensive" military posture.
- Crude oil futures climbed above $90 per barrel following a projectile strike on a commercial vessel in the Strait of Hormuz and the expiration of a 60-day U.S.-Iran memorandum of understanding.
Trump Fast-Tracks Ibogaine Development for Veterans
President Donald Trump announced on Tuesday that the University of Miami has donated its historic 1994 Ibogaine IND application to the federal government. This gift, received by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., is expected to dramatically shorten the regulatory timeline for Ibogaine by providing the FDA with immediate access to decades of foundational research.
The announcement follows an Executive Order signed in April 2026 designed to accelerate medical treatments for serious mental illness. The administration has already allocated $50 million in HHS research funding and established a five-year collaboration between the HHS and the Department of Veterans Affairs (VA) to prioritize psychedelic-assisted therapies for PTSD and traumatic brain injury (TBI).
Advocates, including podcaster Joe Rogan, have long championed Ibogaine—a psychoactive compound derived from an African shrub—for its potential to "reset" the brain in patients with severe addiction. The administration is moving to ensure that veterans have a Right to Try these treatments domestically, potentially reclassifying the drug from its current Schedule I status if clinical trials prove successful.
Iran Rejects Ceasefire as Maritime Conflict Intensifies
Geopolitical stability remains fragile as Iran’s Foreign Minister Abbas Araghchi stated Tuesday that the "war must end" on Iranian terms, ruling out further ceasefire negotiations. The 60-day memorandum of understanding (MOU) between the U.S. and Iran expired without a permanent agreement, leading Tehran to announce a shift to a "fully offensive" military posture.
The conflict has severely impacted global energy markets, with crude oil prices surging after a commercial vessel was struck by an "unknown projectile" in the Strait of Hormuz. The U.K. Maritime Trade Operations (UKMTO) reported one casualty and engine room damage from the strike, further complicating efforts to reopen the vital shipping lane.
In Washington, President Trump called for Tehran to "raise the white flag of surrender" and threatened military action against any nation obstructing U.S. efforts to secure the strait. Meanwhile, Turkish President Tayyip Erdogan has reportedly urged the U.S. to pursue further de-escalation talks to prevent a wider regional conflagration.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.